Both the Pediacel® vaccine and the Pentacel® vaccine are pentavalent vaccines used to protect against diphtheria, tetanus, pertussis, polio and Haemophilius influenzae type b (Hib) in children from the age of 2 months, and in children up to 6 years of age (prior to their 7th birthday). [...] Although there are differences in the presentation between Pediacel® and Pentacel®, they are equivalent and interchangeable. [...] If an infant has received one or two doses of Pediacel®, can the primary series be completed with Pentacel®? [...] Yes. As recommended by the National Advisory Committee on Immunization (NACI), “The routine primary immunization series of diphtheria toxoid, tetanus toxoid, pertussis, poliomyelitis, Haemophilus influenzae type b-containing vaccine should be completed with an appropriate combination vaccine from the same manufacturer whenever possible. [...] there are no concerns with the safety and quality of the Pediacel® vaccine. Q4. [...] Although you are discontinuing the production of Pediacel® vaccine, can providers use their remaining inventory of this vaccine? [...] Yes. The doses of Pediacel® vaccine that will be distributed in 2024 can be used until the expiration date (please refer to the date listed on the packaging).MAT-CA-2400396 V1.0 03/2024 Q6. [...] What are the differences between Pediacel® and Pentacel®? [...] Does the difference in non-active excipients result in any patient impact? [...] Who can I contact in case of any product-specific questions related to the new Pentacel?
- Pages
- 3
- Published in
- Canada
